{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T01:18:11Z","timestamp":1766711891717},"reference-count":37,"publisher":"Elsevier BV","issue":"9405","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/s0140-6736(03)15394-9","type":"journal-article","created":{"date-parts":[[2004,1,25]],"date-time":"2004-01-25T03:27:43Z","timestamp":1075001263000},"page":"320-324","source":"Crossref","is-referenced-by-count":15,"title":["Scaling-up treatment for HIV\/AIDS: lessons learned from multidrug-resistant tuberculosis"],"prefix":"10.1016","volume":"363","author":[{"given":"Rajesh","family":"Gupta","sequence":"first","affiliation":[]},{"given":"Alexander","family":"Irwin","sequence":"additional","affiliation":[]},{"given":"Mario C","family":"Raviglione","sequence":"additional","affiliation":[]},{"given":"Jim Yong","family":"Kim","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(03)15394-9_bib1","author":"WHO"},{"key":"10.1016\/S0140-6736(03)15394-9_bib2","series-title":"Treating 3 Million by 2005: making it happen, the WHO Strategy","author":"World Health Organization and Joint United Nations Programme on HIV\/AIDS","year":"2003"},{"key":"10.1016\/S0140-6736(03)15394-9_bib3","first-page":"758","article-title":"Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands","volume":"4","author":"Geerligs","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1164\/ajrccm.160.2.9901012","article-title":"Outcome of multidrug-resistant tuberculosis in France: a nationwide case-control study","volume":"160","author":"Flament-Saillour","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0140-6736(03)15394-9_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM199510053331404","article-title":"Multidrug-resistant tuberculosis in patients without HIV infection","volume":"333","author":"Telzak","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)15394-9_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.120.2.343","article-title":"Treatment experience of multidrug-resistant tuberculosis in Florida, 1994\u201397","volume":"120","author":"Narita","year":"2001","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(03)15394-9_bib7","first-page":"299","article-title":"Multidrug-resistant tuberculosis in Denmark","volume":"1","author":"Viskum","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib8","first-page":"877","article-title":"Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin","volume":"2","author":"Park","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib9","series-title":"Treatment of Tuberculosis: guidelines for national programmes","author":"WHO","year":"1997"},{"key":"10.1016\/S0140-6736(03)15394-9_bib10","series-title":"Management of tuberculosis: a guide for low income countries","author":"Enarson","year":"2000"},{"key":"10.1016\/S0140-6736(03)15394-9_bib11","series-title":"Guidelines for the management of drug-resistant tuberculosis","author":"WHO","year":"1997"},{"key":"10.1016\/S0140-6736(03)15394-9_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.1061861","article-title":"Responding to market failures in tuberculosis control","volume":"293","author":"Gupta","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0140-6736(03)15394-9_bib13","series-title":"Guidelines for establishing DOTS-plus pilot projects for the management of multidrug-resistant tuberculosis","year":"2001"},{"key":"10.1016\/S0140-6736(03)15394-9_bib14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(00)04268-9","article-title":"Drug-resistant tuberculosis: desperate measures?","volume":"357","author":"Cullinan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)15394-9_bib15","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1046\/j.1365-3156.2002.00960.x","article-title":"Increasing transparency in partnerships for health\u2013introducing the Green Light Committee","volume":"7","author":"Gupta","year":"2002","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S0140-6736(03)15394-9_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa022928","article-title":"Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru","volume":"348","author":"Mitnick","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)15394-9_bib17","first-page":"S204","article-title":"Outcome of multidrug-resistant tuberculosis treatment in patients given individualised therapy, Latvia, 2000","volume":"7","author":"Riekstina","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib18","unstructured":"World Health Organization. Rreport of the meeting of the stop TB working group on DOTS-plus for MDR-TB. 27\u201328 October, 2003. In preparation."},{"key":"10.1016\/S0140-6736(03)15394-9_bib19","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0140-6736(02)08830-X","article-title":"Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru","volume":"359","author":"Suarez","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)15394-9_bib20","first-page":"1078","article-title":"Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?","volume":"5","author":"Gupta","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1472-9792(02)00078-1","article-title":"From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift","volume":"83","author":"Kim","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib22","first-page":"651","article-title":"Evidence and uncertainties","volume":"6","author":"Gupta","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib23","first-page":"410","article-title":"A prioritised research agenda for DOTS-plus for multidrug-resistant tuberculosis (MDR-TB)","volume":"7","author":"Gupta","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(03)15394-9_bib24","series-title":"Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach","author":"WHO","year":"2002"},{"key":"10.1016\/S0140-6736(03)15394-9_bib25","series-title":"Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach: 2003 revision","author":"WHO","year":"2003"},{"key":"10.1016\/S0140-6736(03)15394-9_bib26","series-title":"Access to antiretroviral treatment and care: the experience of the HIV equity initiative, Cange, Haiti","author":"Mukherjee","year":"2003"},{"key":"10.1016\/S0140-6736(03)15394-9_bib27","series-title":"Scaling up antiretroviral therapy: experience in Uganda","author":"Okero","year":"2003"},{"key":"10.1016\/S0140-6736(03)15394-9_bib28","unstructured":"M\u00e8decins Sans Fronti\u00e9res-South Africa, Department of Public Health at the University of Cape Town, and the Provincial Administration of the Western Cape, South Africa. Antiretroviral therapy in primary health care: experience of Khayelitsha programme in South Africa. Geneva: World Health Organization, 2003."},{"key":"10.1016\/S0140-6736(03)15394-9_bib29","series-title":"Saving mothers, saving families: the MCTC-Plus initiative","author":"Rabkin","year":"2003"},{"key":"10.1016\/S0140-6736(03)15394-9_bib30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(02)11478-4","article-title":"Antriretroviral treatment in resource-poor settings: clinical research priorities","volume":"360","author":"Rabkin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)15394-9_bib31","article-title":"Eli Lilly, Health Officials join to fight tuberculosis","author":"Zimmerman","year":"2003","journal-title":"Wall Street Journal"},{"key":"10.1016\/S0140-6736(03)15394-9_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(03)12331-8","article-title":"Out-licensing: a practical approach for improvement of access to medicines in poor countries","volume":"361","author":"Friedman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)15394-9_bib33","series-title":"Pan American Health Organization's revolving fund: children vaccine commission working paper, 1999","author":"Freeman","year":"1999"},{"key":"10.1016\/S0140-6736(03)15394-9_bib34","author":"WHO"},{"key":"10.1016\/S0140-6736(03)15394-9_bib35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.327.7423.1104","article-title":"Tackling HIV in resource poor countries","volume":"327","author":"Mukherjee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(03)15394-9_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(01)05550-7","article-title":"Community-based approaches to HIV treatment in resource-poor settings","volume":"358","author":"Farmer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)15394-9_bib37","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(03)15107-0","article-title":"Global health improvement and WHO:shapingthe future","volume":"362","author":"Lee","year":"2003","journal-title":"Lancet"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673603153949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673603153949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T06:52:41Z","timestamp":1550213561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673603153949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":37,"journal-issue":{"issue":"9405","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0140673603153949"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(03)15394-9","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}